KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Palvella Therapeutics (PVLA) Return on Invested Capital (2016 - 2019)

Palvella Therapeutics has reported Return on Invested Capital over the past 6 years, most recently at 0.02% for Q3 2019.

  • Quarterly Return on Invested Capital fell 2.0% to 0.02% in Q3 2019 from the year-ago period, while the trailing twelve-month figure was 0.02% through Sep 2019, down 2.0% year-over-year, with the annual reading at 0.01% for FY2020, N/A changed from the prior year.
  • Return on Invested Capital was 0.02% for Q3 2019 at Palvella Therapeutics, down from 0.02% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q2 2018 and troughed at 0.04% in Q3 2017.
  • The 5-year median for Return on Invested Capital is 0.01% (2018), against an average of 0.01%.
  • Year-over-year, Return on Invested Capital soared 1207bps in 2015 and then decreased -2bps in 2017.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2015, then decreased by -22bps to 0.01% in 2016, then plummeted by -271bps to 0.02% in 2017, then skyrocketed by 65bps to 0.01% in 2018, then plummeted by -183bps to 0.02% in 2019.
  • Per Business Quant, the three most recent readings for PVLA's Return on Invested Capital are 0.02% (Q3 2019), 0.02% (Q2 2019), and 0.01% (Q1 2019).